Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Limited effects of beta-endorphin compared to loperamide or fentanyl in a neuroendocrine biomarker assay in non-human primates.

Psychoneuroendocrinology - 1 Apr 2008

Butelman Eduardo R, Reed Brian, Chait Brian T, Mandau Marek, Yuferov Vadim, Kreek Mary Jeanne

Abstract excerpt

The in vivo pharmacodynamics of the opioid neuropeptide beta-endorphin (a major endogenous agonist at the mu-opioid receptor) is difficult to determine in non-human primate models with translational value, or in humans. The present studies therefore employed a neuroendocrine biomarker assay, prol...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Analgesics, Opioid
Share to Biotransformation
Share to Fentanyl

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Injections, Intravenous

Share to Naltrexone

Share to Narcotic Antagonists

Share to Neurosecretory Systems

Share to Receptors, Opioid, mu

Source

Open in PubMed Open full text

Identifiers

PMID: 18171605
DOI: 10.1016/j.psyneuen.2007.11.011
PMCID: PMC2275163

Genes

OPRM1

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-18171605-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Limited effects of beta-endorphin compared to loperamide or fentanyl in a neuroendocrine biomarker assay in non-human primates.PMID 18171605Read ↗

What Can We Learn from Rodents about Prolactin in Humans?Semantic proximity Read ↗

Pituitary cocaine- and amphetamine-regulated transcript expression depends on the strain, sex and oestrous cycle in the rat.Semantic proximity Read ↗

Inter-individual divergence in thresholds for detecting opioid effects: Within-subject human laboratory evidence of a testable behavioral phenotype.Semantic proximity Read ↗

D-fenfluramine-induced prolactin responses in postwithdrawal alcoholics and controls.Semantic proximity Read ↗

A first-in-human oral dose study of mesdopetam (IRL790) to assess its safety, tolerability, and pharmacokinetics in healthy male volunteers.Semantic proximity Read ↗

Reliable variability in subjective responses to parenteral hydromorphone administration: empirical confirmation of an opioid non-responder phenotype.Semantic proximity Read ↗

Low efficacy opioids: implications for sex differences in opioid antinociception.Semantic proximity Read ↗

Serotonergic function in cocaine addicts: prolactin responses to sequential D,L-fenfluramine challenges.Semantic proximity Read ↗

The corticotropin-releasing factor receptor-2 mediates the motivational effect of opiate withdrawal.Semantic proximity Read ↗

No effect of MDR1 C3435T variant on loperamide disposition and central nervous system effects.Semantic proximity Read ↗

“Less is more”: a dose-response account of intranasal oxytocin pharmacodynamics in the human brainSemantic proximity Read ↗

Acute opioid administration induces hypothalamic-pituitary-adrenal activation and is mediated by genetic variation in interleukin (Il)1B.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.